by October Gallery
(Reuters) – Regeneron Pharmaceuticals Inc and Sanofi SA will slash the price of their expensive cholesterol drug for Express Scripts Holdings Co customers in exchange for greater patient access, with…
HAIFA, Israel (Reuters) – Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said the U.S. Food and Drug Administration has cleared the emergency use of its therapy to…
NEW YORK (Reuters) – Allergan Plc on Friday announced positive results from a second Phase III trial for the 50 milligram dose of its drug for acute migraine, reproducing results…
HARARE (Reuters) – Zimbabweans can now apply for licences to grow cannabis for medical and research purposes, the government has said in a legal notice, making the southern African nation…
(Reuters) – Fourteen more people fell ill from an E. coli outbreak linked to romaine lettuce, U.S. health officials said on Friday, bringing the number of people affected to 98…
(Reuters) – Fourteen more sick people from eight U.S. states were added to an investigation of an E. coli outbreak linked to romaine lettuce, the U.S. Centers for Disease Control…
(Reuters) – Johnson & Johnson on Wednesday secured a favorable U.S. appellate court ruling, overturning a verdict that had awarded $151 million to five people who blamed injuries they suffered…
(Reuters) – The U.S. Food and Drug Administration on Tuesday said it launched a crackdown on the sale of e-cigarettes and tobacco products to minors, particularly those developed by Juul…
FRANKFURT (Reuters) – U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement. FILE PHOTO: Fresenius headquarters in…
(Reuters) – Pfizer Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve the company’s biosimilar to Roche’s breast cancer drug, Herceptin, and sought additional technical…